The pharmaceutical contract manufacturing (PCM) industry continues to grow at a steady pace, driven by cost pressures, stringent regulatory requirements and patent expiries.

The highly competitive nature of the industry has been driving consolidation and companies are increasingly offshoring to emerging markets to reduce costs. As a result, players in key outsourcing destinations have been improving their manufacturing infrastructure to increasing their global competitiveness.

This report examines the competitive landscape of the global PCM industry. The latest key issues and developments in the contract manufacturing market are identified and leading companies in this sector are profiled in detail.

For each of the top 10 CMO companies, this report provides a detailed examination of financial performance by business segment, manufacturing and R&D capacity, growth strategies and key acquisitions/divestments.

This report also examines the size and growth of the global CMO industry, with analysis of major market drivers and trends in CMO destinations.

Key Findings:

- The global PCM market was worth $26bn in 2007 and is expected to grow at a CAGR of 11.4% to reach $40bn by 2011

- Catalent is the largest CMO in the world, with revenues of $1.8bn in 2007. The PCM market is highly fragmented, with the top ten players in the market holding less than 30% of total market share

- Contract manufacturing in India and China is forecast to expand at a CAGR of 20% through to 2011. Big Pharma are increasingly outsourcing manufacturing to low cost destinations due to cost and margin pressures, and India and China offer skilled manpower and a robust manufacturing infrastructure

- Piramal is the largest CMO in India, and its contract manufacturing revenues increased by 33.3% in dollar terms between 2007-2008. The primary contributor to this growth was it’s PMS segment

- Biopharmaceutical manufacturing is forecast to have increased by 15% in 2008, driven by sales growth of biologics. Lonza, a leading player in this field, registered revenue growth of 75.9% in 2007.


Use this report to:

- Compare the performances of the top 10 CMO companies across key business segments with this report’s analysis of Catalent, Lonza, Boehringer Ingelheim (BI), DSM, Patheon, Evonik, Piramal, Jubilant, Aenova, Fareva

- Identify the market dynamics of the global PCM industry over the 2003-07 period, discover which emerging markets are becoming the CMO destinations of the future and understand the major issues affecting key industry players

- Assess the future prospects of the top 10 CMO companies with this report’s analysis of each firm’s manufacturing and R&D capability, growth strategies and M&A activity

- Measure the progress of other leading CMO companies by evaluating the financial performances of Nipro, Siegfried, Haupt, Divi’s Laboratories (Divi’s), Cambrex, Recipharm, Archimica, Vetter, Famar and NextPharma.

Explore issues including:

Increased offshore outsourcing: Although Europe remains the biggest market for pharmaceutical outsourcing, Asia Pacific will expand rapidly over the coming years due to significant advantages over Eastern Europe and emerging countries such as Brazil, Taiwan and Korea.

Stringent regulatory requirements: CMOs must receive approval from international regulatory bodies such as the FDA in order to establish credibility. Such approvals are difficult to obtain and require compliance with a number of stringent norms.

Growth of biopharma manufacturing: Biopharmaceutical contract manufacturing is the fastest growing segment of contract manufacturing, and players in this field are expanding capacities to meet the rising demand.

Industry consolidation: The PCM industry is experiencing a significant amount of M&A activity due to the presence of a large number of small players. Indian companies in particular have engaged in aggressive M&A activity, with Jubilant’s acquisition of DRAXIS and Hollister-Stier and Piramal’s acquisition of Avecia Pharmaceuticals.

Discover:

- What are the key trends in the global PCM industry?

- Which countries are the hotspots for contract manufacturing?

- Who are the top 10 players in the industry?

- How are the top 10 players positioned?

- How will consolidation change the dynamics of the industry?

- What are the key strategies of the leading CMO companies?

- Which regions and segments offer the greatest growth opportunities?

- What is the future outlook for the industry


Table of Contents



144 pages

Publication Date : March 2009